Fingerprint
Dive into the research topics of 'RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer disease
Kilian M. Gust, Matthias D. Hofer, Sven R. Perner, Robert Kim, Arul M. Chinnaiyan, Sooryanarayana Varambally, Peter Moller, Ludwig Rinnab, Mark A. Rubin, Jochen Greiner, Michael Schmitt, Rainer Kuefer*, Mark Ringhoffer
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
66
Scopus
citations